
City Therapeutics Inc.
CTY | NASDAQ
$21.08
+$0.37 (+1.79%)
Nov 2, 2026, 11:48 AM ET · Market open
Fiscal Year Period Ending | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 2M | 5M | 1M | 5M | 3M | 6M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 515M | 407M | 454M | 567M | 705M | 854M |
Receivables | 514M | 546M | 646M | 700M | 688M | 740M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.97B | 1.3B | 1.12B | 1B | 911M | 1.1B |
Total Current Assets | 2.49B | 1.85B | 1.77B | 1.71B | 1.6B | 1.85B |
Property-Plant & Equipment | 8.17B | 8.08B | 7.92B | 7.65B | 7.37B | 7.2B |
Goodwill & Intangibles | 9.83B | 10.25B | 10.72B | 11.23B | 11.79B | 12.39B |
Total Long-Term Assets | 18.51B | 18.74B | 19.1B | 19.44B | 19.87B | 20.61B |
Total Assets | 21B | 20.58B | 20.87B | 21.15B | 21.47B | 22.46B |
Account Payables | 403M | 441M | 317M | 398M | 369M | 464M |
Deferred Revenue | 201M | 212M | 128M | 131M | 137M | 327M |
Short-Term Debt | 1.11B | 11M | 17M | 514M | 242M | 117M |
Other Current Liabilities | 1.7B | 1.61B | 1.73B | 1.75B | 1.67B | 1.35B |
Total Current Liabilities | 3.41B | 2.27B | 2.2B | 2.8B | 2.42B | 2.26B |
Long-Term Debt | 4.85B | 5.95B | 7.26B | 6.75B | 7B | 7.26B |
Other Long-Term Liabilities | 515M | 547M | 82M | 66M | 60M | 80M |
Total Long-Term Liabilities | 6.67B | 7.68B | 8.48B | 8.72B | 9.09B | 9.74B |
Total Liabilities | 10.88B | 10.72B | 11.53B | 12.46B | 12.56B | 13.27B |
Total Debt | 5.95B | 5.96B | 7.28B | 7.26B | 7.24B | 7.38B |
Book Value | 10.12B | 9.87B | 9.34B | 8.69B | 8.91B | 9.18B |
Book Value Per Share | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B |
Retained Earnings | 67M | -182M | -713M | -1.36B | -1.14B | -867M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 10.12B | 9.87B | 9.34B | 8.69B | 8.91B | 9.18B |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CTY